German doctors cite knowledge gaps and regulatory barriers to prescribing…
[Why are German doctors reluctant to prescribe cannabis?].
AI Summary
This study asked why doctors in Germany may be reluctant to prescribe medicinal cannabis. Researchers analyzed questionnaire responses from 153 volunteer physicians who attended occupational health training seminars; data were collected in 2018, 2020 and 2024. The survey assessed doctors’ knowledge, attitudes and prescribing practices, rather than testing cannabis as a treatment.
Doctors reported limited knowledge of medicinal cannabis, and as many as 70% did not answer some scenario-based knowledge questions correctly. Only 16.3% said they had prescribed medicinal cannabis. Respondents cited regulatory hurdles, including documentation demands and fear of legal consequences, as well as limited knowledge and concern about attracting drug users. Knowledge and attitudes did not show significant change over the survey years. Because participants were volunteers from training seminars, the findings may not represent all German doctors; this survey also cannot establish why prescribing levels are low across the country. This is an abstract-based summary.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Policy research papers you might find interesting.
New York cannabis retailers mostly discouraged pregnancy use, but advice varied
Washington convictions fell after legalization, while disparity trends were…
Canadian survey finds warnings and promotions reach different cannabis users
Explore More Research
Stay informed about the latest cannabis science.